ID: ALA6516

Max Phase: Preclinical

Molecular Formula: C18H19Br3O2

Molecular Weight: 507.06

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(c1ccc(O)c(Br)c1)C(CC)c1cc(Br)c(O)c(Br)c1

Standard InChI:  InChI=1S/C18H19Br3O2/c1-3-12(10-5-6-17(22)14(19)7-10)13(4-2)11-8-15(20)18(23)16(21)9-11/h5-9,12-13,22-23H,3-4H2,1-2H3

Standard InChI Key:  CYHLJVJTZORJDH-UHFFFAOYSA-N

Associated Targets(non-human)

Estrogen receptor 420 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 507.06Molecular Weight (Monoisotopic): 503.8935AlogP: 7.07#Rotatable Bonds: 5
Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 2HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.01CX Basic pKa: CX LogP: 7.67CX LogD: 7.11
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.45Np Likeness Score: 0.50

References

1. Heiman DF, Senderoff SG, Katzenellenbogen JA, Neeley RJ..  (1980)  Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens.,  23  (9): [PMID:7411555] [10.1021/jm00183a007]

Source